Jeroncellevain to Hold 'PDRN Hands-On Course' to Strengthen Clinical Training in Regenerative Dentistry

Jeroncellevain, a company specializing in the production of prescription pharmaceuticals, announced on November 24 that it will hold the "PDRN Total Hands-On Course" seminar at the Shinwon Dental seminar room on November 30.

This hands-on course will provide an in-depth exploration of clinical applications of polydeoxyribonucleotide (PDRN) in the dental medical field. The program integrates both theoretical and practical training.

The curriculum is designed to be practice-oriented, with dental clinical experts covering a wide range of topics-from the principles of PDRN to actual injection techniques, as well as applications for skin and temporomandibular disorders (TMD).

The seminar will begin with an opening by Kim Jaehong, President of the PDRN Immunoregenerative Dental Research Society and Director of Seoul Top Dental Clinic. Presentations will include: Lim Jongwon, Director of Best Dental Clinic, discussing ▲Clinical Cases of PDRN Application in Dentistry; Seol Wonseok, Director of Apple Dental Clinic, covering ▲Maximizing Results with Minimal Equipment; and Yoon Jongil, Vice President of the PDRN Immunoregenerative Dental Research Society and Director of Yeon Dental Clinic, delivering lectures on ▲Understanding PDRN and Clinical & Bone Immunology in Dentistry Parts 1 and 2.

Subsequently, Kim Hyungjun, Director of OFP Oral Medicine Dental Clinic; Kwon Yongdae, Professor at Kyung Hee University Dental Hospital; and Lee Seonjeong, Director of Yonsei SK Dental Clinic, will serve as speakers. They will explain ▲Pathophysiology of Temporomandibular Joint Disorders and PDRN Injection Therapy ▲PDRN Pressure Lift for Transcrestal Approach ▲The Beginning of Dental Aesthetics: Utilizing PDRN, and will lead hands-on sessions on PDRN, TMD, and SKIN.

Yoon Jongil, Vice President of the PDRN Immunoregenerative Dental Research Society and Director of Yeon Dental Clinic, stated, "PDRN demonstrates outstanding efficacy in establishing bone immunology and in anti-inflammatory and tissue regeneration, with its clinical use rapidly expanding in fields such as dentistry and dermatology. Through this hands-on course, we hope medical professionals will acquire more scientific and safe methods for using PDRN, thereby leading to the standardization of regenerative medicine treatments."

Kim Deokgyu, CEO of Jeroncellevain, said, "This hands-on course aims to provide both academic understanding of PDRN-based regenerative treatments and practical, work-centered training that can be immediately applied in clinical settings. Going forward, Jeroncellevain plans to expand PDRN-based regenerative solutions to a variety of medical fields."

Meanwhile, participation in this seminar is available through pre-registration, and all attendees will receive a certificate of completion.

This content was produced with the assistance of AI translation services.